PeerVoice

PeerVoice Internal Medicine Audio

Science EN ↓ 306 episodes

PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Internal Medicine that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.

Author

PeerVoice

Category

Science

Podcast website

www.peervoice.com

Latest episode

Jun 29, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians " 07.11.2022

"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians "

Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat 01.11.2022

Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat

Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022 27.10.2022

Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022

Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure 20.10.2022

Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure

Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals 19.10.2022

Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals

Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC 04.10.2022

Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC

Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice 03.10.2022

Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC 29.09.2022

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC

Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC 20.09.2022

Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART? 20.09.2022

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care 07.09.2022

Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care

Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions 07.09.2022

Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions

Question Time: Applying New Therapies for the Management of mTNBC 29.08.2022

Question Time: Applying New Therapies for the Management of mTNBC

New Biomarkers, New Targets in Advanced NSCLC 17.08.2022

New Biomarkers, New Targets in Advanced NSCLC

Managing Generalised Myasthenia Gravis: A Tale of Two Targets 10.08.2022

Managing Generalised Myasthenia Gravis: A Tale of Two Targets

Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias 01.08.2022

Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias

IAP Antagonists in Oncology: What Do We Know? 25.07.2022

IAP Antagonists in Oncology: What Do We Know?

Advanced Therapy for CPF in Crohn's: Evaluating the Evidence for Stem Cell Therapy and More 12.07.2022

Advanced Therapy for CPF in Crohn's: Evaluating the Evidence for Stem Cell Therapy and More

Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC 11.07.2022

Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC

Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022 30.06.2022

Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022

How I Treat: Achieving Healing in CPF 07.06.2022

How I Treat: Achieving Healing in CPF

Perspectives on the Management of CPF: Moving the Goalposts With Shared Decision-Making 07.06.2022

Perspectives on the Management of CPF: Moving the Goalposts With Shared Decision-Making

Lupus and the Kidney: Emerging Treatment Strategies and How to Use Them 07.06.2022

Lupus and the Kidney: Emerging Treatment Strategies and How to Use Them

Evolving Clinical Management of the Hospitalised COVID-19 Patient 30.05.2022

Evolving Clinical Management of the Hospitalised COVID-19 Patient

Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World 24.05.2022

Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World

Listen to the PeerVoice Internal Medicine Audio podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.